AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 119 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2019 | $4,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | -20.0% | 200 | -24.8% | 0.00% | – |
| Q4 2018 | $5,000 | 0.0% | 266 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | 0.0% | 266 | 0.0% | 0.00% | – |
| Q2 2018 | $5,000 | 0.0% | 266 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | +25.0% | 266 | +33.0% | 0.00% | – |
| Q4 2017 | $4,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q3 2017 | $4,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | +33.3% | 200 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | -25.0% | 200 | -13.8% | 0.00% | – |
| Q4 2016 | $4,000 | 0.0% | 232 | +16.0% | 0.00% | – |
| Q3 2016 | $4,000 | +33.3% | 200 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | – |
| Q4 2015 | $3,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LAM GROUP, INC. | 128,000 | $5,886,720 | 5.78% |
| Beacon Harbor Wealth Advisors, Inc. | 103,095 | $4,741 | 1.58% |
| Capital Impact Advisors, LLC | 15,304 | $703,831 | 1.18% |
| Quantedge Capital Pte Ltd | 36,389 | $1,673,530 | 0.91% |
| Mesirow Institutional Investment Management, Inc. | 183,805 | $8,453,192 | 0.86% |
| Monashee Investment Management LLC | 39,461 | $1,814,811 | 0.76% |
| OBERWEIS ASSET MANAGEMENT INC/ | 152,500 | $7,013,475 | 0.74% |
| Granite Investment Partners, LLC | 330,911 | $15,218,597 | 0.64% |
| Portolan Capital Management | 132,850 | $6,109,772 | 0.57% |
| SHAKER INVESTMENTS LLC/OH | 20,795 | $956,362 | 0.53% |